Utility of whole genome sequencing in assessing risk and clinically relevant outcomes for pulmonary fibrosis is a research paper published in European Respiratory Journal (2022). On theSindex it has a DataRank of 0. It has been cited 46 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Heart, Lung, and Blood Institute
Grant: HL105323
National Heart, Lung, and Blood Institute
Grant: K23HL148498
National Heart, Lung, and Blood Institute
Grant: R01HL093096
NHLBI NIH HHS
Grant: T32 HL105323
NHLBI NIH HHS
Grant: R01 HL130796
NHLBI NIH HHS
Grant: UH3 HL145266
NCATS NIH HHS
Grant: UL1 TR001105
National Institutes of Health
Grant: 5K23HL148498-03
Molecular Markers of Idiopathic Pulmonary Fibrosis Progression
National Institutes of Health
Grant: 1T32HL105323-01A1
Columbia University Training Program in Lung Science
National Institutes of Health
Grant: 7R01HL093096-10
Pulmonary Fibrosis and Telomerase Dysfunction
National Institutes of Health
Grant: 4UL1TR001105-04
UT Southwestern Center for Translational Medicine (UL1/KL2/TL1)
Stony Wold-Herbert Fund
FWCI
4.45
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of KIF15 missense variant is associated with the early onset of idiopathic pulmonary fibrosis
Additional file 1 of KIF15 missense variant is associated with the early onset of idiopathic pulmonary fibrosis